Journal
JOURNAL OF PEDIATRICS
Volume 231, Issue -, Pages 273-+Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jpeds.2020.12.001
Keywords
-
Categories
Ask authors/readers for more resources
The study found no significant difference in death or risk of neurodevelopmental delay between the atropine-propofol group and the atropine-atracurium-sufentanil group in premedication before nonemergency intubation at 2 years of corrected age.
This study followed 173 newborn infants in the PREmedication Trial for Tracheal Intubation of the NEOnate multicenter, double-blind, randomized controlled trial of atropine-propofol vs atropine-atracurium-sufentanil for premedication before nonemergency intubation. At 2 years of corrected age, there was no significant difference between the groups in death or risk of neurodevelopmental delay assessed with the Ages and Stages Questionnaire.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available